AIM Monthly News

AIM continues to hover modestly above all-time lows, with the index having fallen from 401.45 to 389.29 during the past month.

Medical-related stocks heading south on setbacks included drug developer Minster Pharmaceuticals, which surrendered more than 70 per cent on disappointment regarding its migraine treatment. Software developer Medicsight sank 77 per cent after being told by the body running US state-funded medical services that its cancer-screening software does not merit public reimbursement. Notching up a stellar 200 per cent gain was medical device maker Dawmed Systems, which soared after announcing a strong return to profits at the half-year.

In the property sector, developer Terrace Hill fell 38 per cent after announcing losses of £32 million following considerable asset write-downs for the year to October. The company proposes a final dividend of 0.54p a share – much of which will go to chairman and 61 per cent shareholder Robert Adair.

The receipt of takeover offers injected some life into the share prices of tiny marketing services counter Cagney, up 182 per cent over the past four weeks to 0.78p; property developer Red Leopard, up 233 per cent to 0.1p; and head-hunter Hexagon Human Capital, up 28 per cent to 45.5p.